Search

Your search keyword '"Taguchi, Ayumi"' showing total 467 results

Search Constraints

Start Over You searched for: Author "Taguchi, Ayumi" Remove constraint Author: "Taguchi, Ayumi"
467 results on '"Taguchi, Ayumi"'

Search Results

2. Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin

7. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

12. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia

16. Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases

19. Heterogeneous treatment effect of dose‐dense paclitaxel plus carboplatin therapy for advanced ovarian cancer.

22. Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging

23. Synthetic lethality from the combination of a histone methyltransferase, SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma

24. Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification

29. Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids

30. Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

31. Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3

35. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation

36. Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group

40. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations

41. Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.

45. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes

47. Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study

48. Application of organoid culture from HPV18 ‐positive small cell carcinoma of the uterine cervix for precision medicine

Catalog

Books, media, physical & digital resources